Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
190 hedge funds and large institutions have $2.66B invested in Portola Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 86 increasing their positions, 44 reducing their positions, and 16 closing their positions.
125% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 16
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
95% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 44
26% more capital invested
Capital invested by funds: $2.11B → $2.66B (+$555M)
11% more funds holding
Funds holding: 171 → 190 (+19)
35% less call options, than puts
Call options by funds: $9.91M | Put options by funds: $15.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
+$36.4M |
| 2 |
Millennium Management
New York
|
+$28.6M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$27.9M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$27.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$24.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$52M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$46.4M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$45.5M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$17.6M |
| 5 |
BCM
BBT Capital Management
Fort Worth,
Texas
|
-$8.52M |
PTLA Hedge Fund Activity: Q4 2015 in Review
190 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q4 2015, worth a combined $2.66B — up 26% from $2.11B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new PTLA positions and 16 closed out — a net gain of 20 holders — while 86 added to existing stakes and 44 trimmed.
The largest buyer was Temasek Holdings, adding an estimated $36.4M. The largest seller was MPM Asset Management, exiting entirely with an estimated $52M sold.
- 190 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q4 2015, up from 171 in Q3 2015.
- Funds reported $2.66B of Portola Pharmaceuticals, Inc. stock for Q4 2015, up 26% quarter-over-quarter.
- 36 funds opened new Portola Pharmaceuticals, Inc. positions in Q4 2015 and 16 closed out, a net change of +20 holders.
- The largest Portola Pharmaceuticals, Inc. buyer in Q4 2015 was Temasek Holdings, an estimated $36.4M added.
- The largest Portola Pharmaceuticals, Inc. seller in Q4 2015 was MPM Asset Management, an estimated $52M sold.
Based on aggregated 13F filings for Q4 2015.